Carillon Tower Advisers’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,060,804
Closed -$20.6M 423
2018
Q2
$20.6M Hold
2,060,804
0.16% 211
2018
Q1
$20.3M Hold
2,060,804
0.16% 206
2017
Q4
$30.6K Buy
+2,060,804
New +$30.6K 0.33% 110